Analyst Reco. QuidelOrtho Corporation

Equities

QDEL

US2197981051

Real-time Estimate Cboe BZX Other stock markets 16:52:23 29/04/2024 BST			5-day change	1st Jan Change
40.76 ^USD	+2.84%		+4.70%	-44.48%

04-02	QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	MT
04-02	QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Downgrades QuidelOrtho to Sell From Neutral, Adjusts Price Target to $42 From $70	03-04	MT
William Blair Downgrades QuidelOrtho to Market Perform From Outperform	02-14	MT
Citigroup Adjusts Price Target on QuidelOrtho to $50 From $72, Maintains Neutral Rating	02-14	MT
Craig-Hallum Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $50 From $158	02-14	MT
Raymond James Downgrades QuidelOrtho to Outperform From Strong Buy, Cuts Price Target to $76 From $100	02-14	MT
JPMorgan Downgrades QuidelOrtho to Underweight From Neutral, Adjusts Price Target to $37 From $66	02-14	MT
RBC Adjusts PT on QuidelOrtho to $81 From $130, Notes Worse-Than-Anticipated COVID Headwinds; Outperform Kept on 'Compelling' Risk/Reward	02-14	MT
RBC Cuts Price Target on QuidelOrtho to $130 From $140, Keeps Outperform Rating	12-21	MT
Citigroup Downgrades QuidelOrtho to Neutral From Buy, Cuts Price Target to $72 From $95	12-11	MT
Raymond James Adjusts QuidelOrtho's Price Target to $110 From $130, Keeps Strong Buy Rating	15/08/23	MT
RBC Raises QuidelOrtho's Price Target to $136 From $133, Keeps Outperform Rating	17/07/23	MT
UBS Adjusts QuidelOrtho Price Target to $98 From $99, Maintains Neutral Rating	17/05/23	MT
RBC Boosts Price Target on QuidelOrtho to $133 From $130, Maintains Outperform Rating	04/05/23	MT
RBC Cuts Price Target on QuidelOrtho to $130 From $136, Maintains Outperform Rating	14/04/23	MT
RBC Cuts Price Target on QuidelOrtho to $130 From $136, Maintains Outperform Rating	13/04/23	MT
UBS Adjusts QuidelOrtho Price Target to $99 From $93, Maintains Neutral Rating	22/02/23	MT
Raymond James Cuts QuidelOrtho's Price Target to $130 From $136, Maintains Strong Buy Rating	16/02/23	MT
RBC Raises Price Target on QuidelOrtho to $136 From $125 After 'Strong' Q4, Above-Street 2023 Guidance, Maintains Outperform Rating	16/02/23	MT
Citigroup Upgrades QuidelOrtho to Buy From Neutral, Adjusts Price Target to $125 From $90	12/12/22	MT
RBC Initiates QuidelOrtho at Outperform With $125 Price Target, Sees Potential for Market Share Gains, Sales Acceleration Beyond 2024	07/12/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. QuidelOrtho Corporation

Equities

QDEL

US2197981051

Analyst Reco.

Filters